Delivery Order HHSN261201600003I-HHSN26100001

This is a $94,681,492.36 definitive cost-no-fee contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to The Broad Institute, Inc., a non-profit biomedical and genomic research organization. The contract is to provide a laboratory, data analysis, and coordinating center for the Genotype-Tissue Expression (GTEx) project, a National Institutes of Health Common Fund initiative. The contract includes two major...

This is a $37,876,167 Firm Fixed Price definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization. The contract supports the Trans-Omics for Precision Medicine (TOPMed) initiative through genomics data generation, analysis, and management services. This is an indefinite delivery contract with a 10-year, $500 million ceiling. The Broad Institute was also awarded a multiple-award Indefinite Delivery Indefinite...

This is a $13,468,050.00 definitive, firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for special studies and analysis services, with no set-aside designation. NYGC has a $500 million indefinite delivery, indefinite quantity (IDIQ) contract with NHLBI for the Trans-Omics for Precision Medicine (TOPMed) program to provide...

The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...

This federal contract award, valued at $20,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Genedx, LLC, a wholly owned subsidiary of Opko Health, Inc. The contract provides for the Genedx Hereditary MDS/Leukemia Panel (T830) and Copy Number Variation (CNV) testing services to be made available to potential participants who do not otherwise have access to this genetic testing. The contract is structured as a firm fixed-price purchase order with a period of...

This is a $37,262,683.59 definitive cost-no-fee contract awarded by the National Cancer Institute (NCI) to The International Genomics Consortium. The contract is for providing biospecimen processing services to support the Cancer Genome Atlas (TCGA) program, which is part of the National Institutes of Health's efforts to comprehensively characterize various cancer types. The contract has an ultimate completion date of December 30, 2012 and was awarded on September 24, 2010 as part of the...

The National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. government, has awarded a $46,984.32 firm-fixed-price purchase order contract to The Regents of the University of California, San Francisco (UCSF) for AFFE GENE TITAN AXIOM, 8 WHOLE GENOME DNA GENOTYPING FOR 864 SAMPLES. This contract, which does not have a set-aside designation, originates from a solicitation for whole genome DNA genotyping services related to Systemic Lupus Erythematosus (SLE) research....

This is a $495,000 firm fixed price delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Johns Hopkins University. The purpose of the contract is to conduct high throughput genotyping to study the genetic contributions to human disease as part of the NINDS (National Institute of Neurological Disorders and Stroke) Genome-Wide Association Studies (GWAS) program. The contract supported the...

The National Heart, Lung and Blood Institute of the Department of Health and Human Services National Institutes of Health awarded a $954,000 firm fixed price delivery order to The Broad Institute, Inc. under the Centralized Omic REsource for TOPMed (CORE) multiple award indefinite delivery/indefinite quantity contract vehicle. This delivery order is for whole genome sequencing services to support somatic mutation identification in the Genotype-Tissue Expression (GTEx) program. No set-aside...

This federal contract award, valued at $166,819,979.48, was issued by the National Cancer Institute (NCI) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard), a non-profit biomedical and genomic research organization. The contract is for the Sequencing for the Cancer Genome Atlas (TCGA) Program, which supports the generation and analysis of genomic data to advance cancer research. The Broad Institute will provide a range of scientific services, including genomic...